Kano Therapeutics
Latest round
- Seed
Last raised
- May 2024
Total raised
- $5M
Investors
- 4
About Kano Therapeutics
Based in Massachusetts, US, and founded in 2021, Kano Therapeutics Inc. a spin-off of MIT, operates as a biotechnology company that engages in the development of a new class of biomaterials for gene correction. In May 2024, Kano Therapeutics Inc. Kano Therapeutics primarily serves scientists, labs, and companies in the biotechnology industry. The company is dedicated to pioneering targeted gene correction using circular single-stranded (donor) DNA (ssDNA). Kano’s ssDNA technique combines the stability of double-stranded DNA with the flexibility of RNA, offering superior building blocks for genomic engineering. As of May 2024, the company has developed a fermentation-based production technique for ssDNA, enabling the creation of gene-length circular ssDNA templates. This innovation overcomes traditional manufacturing bottlenecks, supports longer DNA insertions, and unlocks gene editing targets. Kano's platform integrates design, manufacturing, and screening processes to provide a solution for partners seeking to develop gene replacement therapies.
Who invested in Kano Therapeutics
4 investors across 1 round
See all investors in Kano Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 6, 2024
Amount
$5M
Investors
Questions about Kano Therapeutics
Who invested in Kano Therapeutics?
Kano Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kano Therapeutics raised?
Kano Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kano Therapeutics last raise money?
Kano Therapeutics's most recent round on record is a Seed, in May 2024.
What does Kano Therapeutics do?
Based in Massachusetts, US, and founded in 2021, Kano Therapeutics Inc.
Where is Kano Therapeutics headquartered?
Kano Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Kano Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kano Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Kano Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.